This initiative has the potential to bring about significant positive changes in the healthcare sector of Uttar Pradesh and contribute to the overall growth of the region
Overall imports decline 8% in first nine months of FY23
The National Medical Devices Policy, 2023 will pave the way for India to become an 'end-to-end' healthcare resource centre not only for the country, but also for the global needs, industry bodies opined on Thursday. The government on Wednesday approved the new policy with an aim to promote domestic manufacturing and help the sunrise sector grow from the present USD 11 billion to USD 50 billion in the next five years and reduce import dependence. The policy focuses on six strategies to tap the potential of the sector with the 'implementation of action plan'. Ajay Singh, President of Assocham, said regulatory measures like single window for different types of licences, coherent pricing norms and infrastructure for manufacturing and technology advancement, are among the defining features of the new policy, as approved by the Union Cabinet. "While India has established itself as a 'pharmacy of the world', integrated healthcare would require equal emphasis on medical devices. "The new
Empowered group of secretaries, Aayog review some sectors to bring them to 'acceptable levels'
Group wants basic custom duty on import of medical devices increased to 10-15%
Union Minister for Science and Technology Jitendra Singh on Tuesday said India is among the top five countries in the world manufacturing life-saving high-risk medical devices but the cost of our devices is about one-third of those manufactured by the other four countries.Addressing the faculty and students after inaugurating the Combined Devices Block at Chitra Tribunal Institute of Medical Science and Technology here, Singh said, "technologies developed by the Institute like the artificial heart valve, hydrocephalus shunt, oxygenator and drug eluting Intra uterine device are being manufactured in three to four countries like USA, Japan, Brazil and China," said a press release by Ministry of Science & Technology.Singh said the world-class medical devices made indigenously are available to Indian patients at approximately one-fourth to the one-third price of their imported counterparts. He underlined that this reflects the Atmanirbhar vision of PM Modi to become self-reliant in .
The Infosys Prize focuses on the achievements of the recipients and awards them for their contributions to science and research impacting India
Data suggests bulk of the exports will come from largescale electronic manufacturing, which is dominated by mobiles
The Parliamentary Standing Committee on Health and Family Welfare has recommended setting up of a new set of regulators at different levels for regulating the medical Devices industry
Apart from masks, even condoms sold at groceries may be brought within the ambit of the rule; industry feels govt may come out with an exemption list for common items
India currently exports Rs. 23,766 crore (2021-22) of medical devices up from previous year Rs 19,736 crore
Allows self declaration on portal for licensing purposes
The non-invasive, battery-operated device is sensitive to one-hundredth of a millimetre (10 micrometers) and can beam results to a smartphone app wirelessly in real-time with the press of a button.
The report presented in the Parliament by a standing committee stated that along with more testing labs, the country needs a robust IT-enabled and feedback-driven post-sales surveillance system
There are demands to extend production linked incentive (PLI) scheme to more sectors such as certain electronic components, pharma and medical devices, and discussions are underway in the government on these proposals, a senior government official said. Discussions are also going on to bring PLI scheme for toys, furniture, bicycles and containers. The objective of the scheme is to make domestic manufacturing globally competitive, create global champions in manufacturing, boost exports and create jobs. The government last year rolled out the scheme with an outlay of about Rs 2 lakh crore for as many as 14 sectors, including automobiles and auto components, white goods, textiles, advanced chemistry cell (ACC) and speciality steel. "So, from Rs 1.97 lakh crore, there are savings from some sectors. So against those savings, things are being planned. Proposals are under consideration," the official said. Demand for including sectors like certain electronic components, toys, furniture,
The Bill takes regressive steps on the issue of drug safety
India's medical devices imports surged 41 per cent to touch Rs 63,200 crore in 2021-22, led by a 48 per cent year-on-year (YoY) jump in imports from China. Read more in our top headlines
China accounts for about one-fifth of FY22 numbers; 41% surge overall
Centre also proposes to have an expert group on medical devices
Also, for the first time, regulations for conduct of clinical trials for new drugs and medical devices have been brought under the draft New Drugs, Medical Devices and Cosmetics Bill, 2022